P. Fagan

发表

Synthesis of AZT 5'-triphosphate mimics and their inhibitory effects on HIV-1 reverse transcriptase.

P. D. Cook, J. Leeds, T. W. Bruice, 2004, Journal of medicinal chemistry.

Synthesis of 2‘,3‘-Dideoxynucleoside 5‘-α-P-Borano-β,γ-(difluoromethylene)triphosphates and Their Inhibition of HIV-1 Reverse Transcriptase

P. D. Cook, J. Leeds, T. W. Bruice, 2005 .

2′,3′-Dideoxynucleoside 5′-β,γ-(Difluoromethylene) Triphosphates With α-P-Thio or α-P-Seleno Modifications: Synthesis and Their Inhibition of HIV-1 Reverse Transcriptase

N. Boyle, P. Fagan, Jennifer L. Brooks, 2005 .

RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells

W. M. Leevy, R. Deberardinis, M. Overholtzer, 2018, Nature Cell Biology.

Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.

E. Tindall, Kristen M. Smith, E. Lew, 2019, Cancer research.

Breast cancer and induced abortion: a comprehensive review of breast development and pathophysiology, the epidemiologic literature, and proposal for creation of databanks to elucidate all breast cancer risk factors.

A. Lanfranchi, P. Fagan, 2014, Issues in law & medicine.

Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung

Jilly F. Evans, D. Lorrain, P. Prasit, 2010, Journal of Pharmacology and Experimental Therapeutics.

Synthesis of Azole Nucleoside 5′‐Monophosphate Mimics (P1Ms) and Their Inhibitory Properties of IMP Dehydrogenases

P. D. Cook, J. Leeds, T. W. Bruice, 2004, Nucleosides, nucleotides & nucleic acids.

Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis.

Jilly F. Evans, D. Lorrain, P. Prasit, 2011, Bioorganic & medicinal chemistry letters.

Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis.

Jilly F. Evans, D. Lorrain, P. Prasit, 2009, Bioorganic & medicinal chemistry letters.

Synthesis of 5′-Triphosphate Mimics (P3Ms) of 3′-Azido-3′,5′-Dideoxythymidine and 3′,5′-Dideoxy-5′-Difluoromethylenethymidine as HIV-1 Reverse Transcriptase Inhibitors

P. D. Cook, V. Rajwanshi, Guangyi Wang, 2005, Nucleosides, nucleotides & nucleic acids.

RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells

W. M. Leevy, R. Deberardinis, M. Overholtzer, 2018, Nature Cell Biology.

ALK Fusions in Renal Cell Carcinoma: Response to Entrectinib.

H. Al-Ahmadie, M. Arcila, Chung-Han Lee, 2018, JCO precision oncology.

Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3–Positive Acute Myeloid Leukemia

E. Pomari, I. Silverman, Kristen M. Smith, 2017, Molecular Cancer Therapeutics.

A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model

D. Lorrain, P. Prasit, T. J. Seiders, 2010, British journal of pharmacology.

Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.

E. Tindall, Kristen M. Smith, E. Lew, 2019, Cancer research.